Annals of Internal Medicine, tip sheet, January 1, 2002

December 31, 2001

Annals of Internal Medicine is published by the American College of Physicians-American Society of Internal Medicine (ACP-ASIM), an organization of more than 115,000 internal medicine physicians and medical students. The following highlights are not intended to substitute for articles as sources of information. For an embargoed fax of an article, call 1-800-523-1546, ext. 2656 or 215-351-2656.

ACP-ASIM: Pharmacists not qualified to initiate drug therapy

(See attached news release on new ACP-ASIM position paper.)

Six popular herbal therapies have mixed risk-benefit profiles

A review of published data on the effectiveness and safety of six herbal therapies finds:Accurate assessment is difficult, the author says, because existing clinical trials are "too few, too small, and too short"; lack of standardization and quality control make it hard to know what the herbal products contain or if they are free of contamination, and a plethora of books on herbal medicines "represent more of a risk to the health of the reader than a helpful source of knowledge." The author identifies and ranks some newer books on herbal medicines. Although the growing popularity of herbal medicines probably reflects the public perception that they have no negative side effects, the author stresses that all herbal products have some risks (Academia and Clinic, p. 42).

Steroids lessened arthritis symptoms but increased risk for bone fractures

Prednisone, a glucocorticoid, reduced swelling and progression of damage to joints for up to six months in patients with early active rheumatoid arthritis, according to a recent study (Article, p. 1). Prednisone is not often used today as a long-term treatment for arthritis because of its severe side effects. In this study, a daily pill with 10 milligrams of prednisone was compared to a placebo, or dummy pill. Prednisone was not used in combination with the newer disease-modifying antirheumatic drugs (DMARDs) that are known to reduce symptoms and the risk of permanent joint damage. Prednisone causes osteoporosis. Thus, of the 41 patients who took prednisone, five experienced a fracture of the body of one of the vertebrae in their spine, compared to two patients who received the placebo. Authors conclude that prednisone may be useful to treat arthritis when combined with DMARDs. An editorial praises the authors of the study for re-evaluating an 'old' therapy and showing that it may have found a new application (Editorial, p. 76). But the editorial writer cautions that the 10 milligram dose, called a low dose in the study, may still be higher than necessary to achieve the desired results.
-end-


American College of Physicians

Related Arthritis Articles from Brightsurf:

Physical activity and sleep in adults with arthritis
A new study published in Arthritis Care & Research has examined patterns of 24-hour physical activity and sleep among patients with rheumatoid arthritis, lupus, and knee osteoarthritis.

Is rheumatoid arthritis two different diseases?
While disease activity improves over time for most rheumatoid arthritis (RA) patients, long-term outcomes only improve in RA patients with autoantibodies, according to a new study published this week in PLOS Medicine by Xanthe Matthijssen of Leiden University Medical Center, Netherlands, and colleagues.

Does the Mediterranean diet protect against rheumatoid arthritis?
Previous research has demonstrated a variety of health benefits associated with the Mediterranean diet, which is rich in olive oil, cereals, fruit and vegetables, fish, and a moderate amount of dairy, meat, and wine.

Reducing corticosteroid use in rheumatoid arthritis
Is the long-term use of glucocorticoids essential in people with chronic inflammatory diseases such as rheumatoid arthritis, or can early discontinuation prevent characteristic side effects?

Psoriasis onset determines if psoriatic arthritis patients develop arthritis or psoriasis first
In a new study presented at the 2019 ACR/ARP Annual Meeting, researchers found the age of psoriasis onset determines whether arthritis or psoriasis starts first in people with psoriatic arthritis.

The ACR and the Arthritis Foundation present new guidelines offering therapeutic approaches and treatment options for juvenile idiopathic arthritis
Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA).

Does alcohol consumption have an effect on arthritis?
Several previous studies have demonstrated that moderate alcohol consumption is linked with less severe disease and better quality of life in patients with rheumatoid arthritis, but a new Arthritis Care & Research study suggests that this might not be because drinking alcohol is beneficial.

Prospect of a new treatment for rheumatoid arthritis
An international research group led by Charité -- Universitätsmedizin Berlin has completed testing a new drug to treat rheumatoid arthritis.

Can rare lymphocytes combat rheumatoid arthritis?
Immunologists at Friedrich-Alexander-Universität Erlangen-Nürnberg have demonstrated that ILC2, a group of rare lymphoid cells, play a key role in the development of inflammatory arthritis.

Which pain medication is safest for arthritis patients?
In a recent Alimentary Pharmacology & Therapeutics study, arthritis patients taking nonsteroidal anti-inflammatory drugs (NSAIDs) for pain plus a stomach acid-reducing medicine called esomeprazole had infrequent gastrointestinal side effects.

Read More: Arthritis News and Arthritis Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.